Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multidimensional analysis of nutritional status among children under 5 years in Africa, 1990-2024.

Scientific reports·2026
Same author

The Evolving Burden of Stroke in China's 832 Poverty-Alleviated Counties (2019-2024): Nationwide Spatiotemporal Analysis.

JMIR public health and surveillance·2026
Same author

Analysis of the mechanism of roof water hazards caused by fault activation.

Scientific reports·2026
Same author

Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease".

Journal of medicinal chemistry·2026
Same author

Predictive value of delta-radiomic features for the prognosis of patients with stage IA lung adenocarcinoma.

Clinical imaging·2026
Same author

Baseline Mismatch Negativity Amplitude Predicts Direction and Magnitude of Ketamine Effect in Healthy Volunteers: A Disordinal Effect.

Biological psychiatry·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Wang Yuchuan1, Helen J Mitchell1, Susi Lee1

  • 1Merck Sharp & Dohme LLC, West Point, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

这项研究表明,MK-7337,一种新的PET追踪器,可以在帕金森病 (PD) 患者中成功成像α-synuclein (ASYN) 病理. 这一突破使得更好的诊断和跟踪Lewy体疾病的进展.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经成像是一种神经成像.
  • 分子成像学分子成像学
  • 放射化学 放射化学是指辐射化学.

背景情况:

  • 在帕金森病 (PD) 中成像勒维体病理学的临床可行性尚不清楚.
  • 阿尔法-同核素 (ASYN) 是PD和相关的勒维体疾病的关键生物标志物.
  • 新型PET放射性对象的开发对于体内ASYN成像至关重要.

研究的目的:

  • 评估使用新型PET放射性连体在PD患者中成像ASYN病理学的临床可行性.
  • 在第一次在人体 (FIH) 研究中评估[11C]MK-7337的安全性和性能.
  • 为了比较PD患者和健康老年人的ASYN标记物摄入量.

主要方法:

  • 在死后的大脑组织上进行了放射性对象结合测试,以确定亲和力和选择性.
  • 在小鼠模型和非人类灵长类动物 (NHP) 中的体内PET成像验证了标记器性能和翻译适用性.
  • 一项首次在人身上 (FIH) 的研究涉及使用MK-7337.C对八名PD患者和四名健康老年人 (HE) 参与者的PET成像.

主要成果:

  • [11C]MK-7337在体外显示出对ASYN病理的高度亲和力,在体内显示出适当的脑动力学.
  • 在PD患者的PET成像显示,与早期ASYN病理学相关的大脑区域,包括中脑和脑干中,有较高的标记物吸收.
  • 在PD患者,HE参与者和临床前NHP扫描之间观察到类似的标志物分布和清除模式.

结论:

  • [11C]MK-7337是一种可行的PET放射性对象,用于在帕金森病中成像α-synuclein病理.
  • 这种新的成像方法有可能改善PD的诊断和监测.
  • 进一步的研究可以利用这种追踪器来了解疾病的进展和治疗的发展.